The Tax-Relief-and-Medicaid-Cuts Bill Nears the Finish Line, With Four Big Implications for the Pharma Industry
Shares:
Yesterday was all about Eliquis. First up were the patient listening sessions I keep prattling on about. And while there was some sense that the parade of speakers didn’t shed
If you want to search Cost Curve back issues or link to anything you read here, the web links and archive are online at costcurve.beehiiv.com. You can subscribe there, too.
Plenty of catching up to do today. Thanks for spending your Friday with me. Thank goodness it’s a bye week for the Hockey East-leading Terriers. If you want to search